Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
Lukanova A, Becker S, Hüsing A, Schock H, Fedirko V, Trepo E, Trichopoulou A, Bamia C, Lagiou P, Benetou V, Trichopoulos D, Nöthlings U, Tjønneland A, Overvad K, Dossus L, Teucher B, Boeing H, Aleksandrova K, Palli D, Pala V, Panico S, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Quiros JR, Duell EJ, Molina-Montes E, Chirlaque MD, Gurrea AB, Dorronsoro M, Lindkvist B, Johansen D, Werner M, Sund M, Khaw KT, Wareham N, Key TJ, Travis RC, Rinaldi S, Romieu I, Gunter MJ, Riboli E, Jenab M, Kaaks R.
Lukanova A, et al. Among authors: boeing h.
Int J Cancer. 2014 Jan 1;134(1):164-73. doi: 10.1002/ijc.28342. Epub 2013 Aug 2.
Int J Cancer. 2014.
PMID: 23801371